TY - JOUR
T1 - Bile acids
T2 - Regulation of apoptosis by ursodeoxycholic acid
AU - Amaral, Joana D.
AU - Viana, Ricardo J.S.
AU - Ramalho, Rita M.
AU - Steer, Clifford J.
AU - Rodrigues, Cecilia M.P.
PY - 2009
Y1 - 2009
N2 - Bile acids are a group of molecular species of acidic steroids with peculiar physical-chemical and biological characteristics. At high concentrations they become toxic to mammalian cells, and their presence is pertinent in the pathogenesis of several liver diseases and colon cancer. Bile acid cytoxicity has been related to membrane damage, but also to nondetergent effects, such as oxidative stress and apoptosis. Strikingly, hydrophilic ursodeoxycholic acid (UDCA), and its taurine-conjugated form (TUDCA), show profound cytoprotective properties. Indeed, these molecules have been described as potent inhibitors of classic pathways of apoptosis, although their precise mode of action remains to be clarified. UDCA, originally used for cholesterol gallstone dissolution, is currently considered the first choice therapy for several forms of cholestatic syndromes. However, the beneficial effects of both UDCA and TUDCA have been tested in other experimental pathological conditions with deregulated levels of apoptosis, including neurological disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases. Here, we review the role of bile acids in modulating the apoptosis process, emphasizing the anti-apoptotic effects of UDCA and TUDCA, as well as their potential use as novel and alternate therapeutic agents for the treatment of apoptosis-related diseases.
AB - Bile acids are a group of molecular species of acidic steroids with peculiar physical-chemical and biological characteristics. At high concentrations they become toxic to mammalian cells, and their presence is pertinent in the pathogenesis of several liver diseases and colon cancer. Bile acid cytoxicity has been related to membrane damage, but also to nondetergent effects, such as oxidative stress and apoptosis. Strikingly, hydrophilic ursodeoxycholic acid (UDCA), and its taurine-conjugated form (TUDCA), show profound cytoprotective properties. Indeed, these molecules have been described as potent inhibitors of classic pathways of apoptosis, although their precise mode of action remains to be clarified. UDCA, originally used for cholesterol gallstone dissolution, is currently considered the first choice therapy for several forms of cholestatic syndromes. However, the beneficial effects of both UDCA and TUDCA have been tested in other experimental pathological conditions with deregulated levels of apoptosis, including neurological disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases. Here, we review the role of bile acids in modulating the apoptosis process, emphasizing the anti-apoptotic effects of UDCA and TUDCA, as well as their potential use as novel and alternate therapeutic agents for the treatment of apoptosis-related diseases.
KW - Bcl-2 family
KW - Cell death
KW - Liver
KW - Neuroprotection
KW - Nuclear steroid receptors
UR - http://www.scopus.com/inward/record.url?scp=70350417325&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350417325&partnerID=8YFLogxK
U2 - 10.1194/jlr.R900011-JLR200
DO - 10.1194/jlr.R900011-JLR200
M3 - Review article
C2 - 19417220
AN - SCOPUS:70350417325
SN - 0022-2275
VL - 50
SP - 1721
EP - 1734
JO - Journal of lipid research
JF - Journal of lipid research
IS - 9
ER -